Barinthus Biotherapeutics plc (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

1.540

-0.042 (-2.65%)

Oct 8, 2025, 2:06 PM EDT - Market open

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
Immunotherapies and Vaccines	14.97M	Log In	Log In	Log In	Log In	Upgrade
Immunotherapies and Vaccines Growth	1766.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2019
United Kingdom	14.97M	Log In	Log In	Log In	Log In	Upgrade
United Kingdom and United States	-	Log In	Log In	Log In	Log In	Upgrade
United Kingdom and United States Growth	-	Log In	Log In	Log In	Log In	Upgrade